Krug, David http://orcid.org/0000-0001-8811-5416
,
Baumann, René
Combs, Stephanie E.
Duma, Marciana Nona
Dunst, Jürgen
Feyer, Petra
Fietkau, Rainer
Haase, Wulf
Harms, Wolfgang
Hehr, Thomas
Piroth, Marc D.
Sedlmayer, Felix
Souchon, Rainer
Strnad, Vratislav
Budach, Wilfried
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 11 December 2020
Accepted: 31 December 2020
First Online: 28 January 2021
Conflict of interest
: D. Krug has received honoraria from Merck Sharp & Dome, outside of the submitted work. J. Dunst is the principal investigator of the HYPOSIB trial. F. Sedlmayer is the principal investigator of the HIOB trial and has received a research grant from IntraOP Medical for the conduct of the trial. All authors, D. Krug, R. Baumann, S.E. Combs, M.N. Duma, J. Dunst, P. Feyer, R. Fietkau, W. Haase, W. Harms, T. Hehr, M.D. Piroth, F. Sedlmayer, R. Souchon, V. Strnad and W. Budach, are members of the German Society for Radiation Oncology (DEGRO).